甲基胺相关的肺动脉高血压:影响,机制和管理框架
Namita Sood1, Jonika Weerasekare1, Iryna Zhyvylo1
1University of California Davis School of Medicine Davis California USA.
Pulmonary circulation
|January 22, 2026
概括
与甲基胺相关的肺动脉高血压 (Meth-PAH) 是一个越来越令人担忧的问题. 本综述提出了一种务实的管理方法,强调早期口腔治疗和多学科护理,以获得更好的结果.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 毒理学 毒理学 毒理学
背景情况:
- 甲基胺相关的肺动脉高血压 (Meth-PAH) 是1组PAH的研究不足的亚型.
- 它的流行率在全球范围内随着甲基胺流行病的增加而增加.
- 对于Meth-PAH没有标准化的诊断标准或治疗指南.
研究的目的:
- 审查Meth-PAH的流行病学,病理生理学,临床管理和治疗挑战.
- 概述一种务实的方法来管理Meth-PAH.
- 为了确定Meth-PAH研究中的关键知识缺口.
主要方法:
- 文献综述总结了有关Meth-PAH的现有数据.
- 关于临床管理策略的建议.
- 确定需要进一步研究的领域.
主要成果:
- 甲基PAH需要对物质使用进行结构化选.
- 建议开始口服PAH特异性疗法,无论是否禁食.
- 治疗升级应基于坚持和连续风险评估.
结论:
- 对于管理Meth-PAH和同时出现的甲基胺使用障碍而言,一个多学科的方法至关重要.
- 需要进一步研究甲基PAH病理生理学,风险分层和活跃使用者的治疗疗效.
- 这种高风险人群的改善结果取决于解决这种情况和物质使用障碍.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
578
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
578
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
445
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
445
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
475
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
475
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
597
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
597
Hypertension V: Nursing Management
378
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
378
Pulmonary Hypertension: Classification and Pathogenesis
593
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
593


